Development of Organizational Technologies for harmaceutical Care to Outpatients (on the Example of Diabetes Mellitus)

Abstract

Taking into account global trends in the development of healthcare, there were scientifically grounded conceptual model of pharmaceutical care to outpatients with diabetes mellitus and the integrated technology of managing processes of pharmaceutical care on the basis of personalization in pharmaceutical care, specialization of pharmacies, modeling procedures of information exchange between medical institutions and pharmacies, optimization of prescription and providing drugs, providing information and consulting services with the use of methods and means of modern information technologies, the development of step-by-step guides for the implementation of control technologies, the creation of a system of continuous professional education of pharmacy specialists in the field of diabetes mellitus.

Authors and Affiliations

A. D. Semionova

Keywords

Related Articles

Immunomodulatory Therapy of Chronic Fatigue Syndrome Associated with Metabolic Syndromе

In 16 patients with chronic obstructive pulmonary disease with metabolic syndrome and chronic fatigue syndrome, we have studied the effect of combined use of noophen and broncho-munal based on the evaluation of clinical...

Change of Anthropometric and Hormonal Indices in Adolescents (Boys) with Slow Somatic and Sexual Development against Therapy

The hormonal indices, particularly average level of TSH, free thyroxine (р < 0.05) have been significantly improving after 3, 6 and 12 months of treatment with potassium iodide (100, 150 мg/day) and levothyroxine (25, 50...

Features of Immune and Metabolic Changes in patients with Combined Endocrine Pathology and Vitamin D3 Deficiency

Aim. To study the cytokines background concentration in patients with combined endocrine pathology — diabetes mellitus (DM) type 1 or 2 and autoimmune thyroiditis secondary to vitamin D3 deficiency. Methods. The examined...

Voglibose in Combination of Three Hypoglycemic Agents in the Treatment of Type 2 Diabetes Mellitus

The aim of the study — ​clinical and metabolic rationale for the selection of the third hypoglycemic agent to enhance the effectiveness of treatment in patients with diabetes mellitus (DM) type 2, assessment of the impac...

Diagnostic algorithm in combined surgical pathology in patients with diseases of endocrine system

Background. Every 2 years, the incidence of endocrine pathology increased by 23–30 %. During the diagnostic search, 25–30 % of patients with endocrine disorders appear to have 2 to 4 combined surgical diseases. The numbe...

Download PDF file
  • EP ID EP229621
  • DOI -
  • Views 74
  • Downloads 0

How To Cite

A. D. Semionova (2014). Development of Organizational Technologies for harmaceutical Care to Outpatients (on the Example of Diabetes Mellitus). Міжнародний ендокринологічний журнал, 8(64), 82-88. https://europub.co.uk/articles/-A-229621